Kyowa Kirin Co., Ltd. Logo

Kyowa Kirin Co., Ltd.

4151.T

(3.5)
Stock Price

2.570,00 JPY

12.58% ROA

11.6% ROE

14.36x PER

Market Cap.

1.388.179.297.250,00 JPY

0% DER

2.2% Yield

20.45% NPM

Kyowa Kirin Co., Ltd. Stock Analysis

Kyowa Kirin Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Kyowa Kirin Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 Net Profit Growth

This company's net profit has consistently grown over the last five years, indicating a strong financial performance and making it an attractive investment opportunity.

4 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

5 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

6 ROE

The stock's ROE falls within an average range (7.39%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

7 ROA

The stock's ROA (7.25%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

8 PBV

The stock's PBV ratio (1.62x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

9 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (25.563) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

11 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

Kyowa Kirin Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Kyowa Kirin Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Kyowa Kirin Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Kyowa Kirin Co., Ltd. Revenue
Year Revenue Growth
1999 374.910.000.000
2000 375.610.000.000 0.19%
2001 378.668.000.000 0.81%
2002 359.285.000.000 -5.39%
2003 348.838.000.000 -2.99%
2004 358.963.000.000 2.82%
2005 353.440.000.000 -1.56%
2006 354.274.000.000 0.24%
2007 392.120.000.000 9.65%
2008 460.183.000.000 14.79%
2009 0 0%
2010 413.738.000.000 100%
2011 343.722.000.000 -20.37%
2012 333.158.000.000 -3.17%
2013 340.611.000.000 2.19%
2014 333.446.000.000 -2.15%
2015 364.316.000.000 8.47%
2016 343.019.000.000 -6.21%
2017 353.380.000.000 2.93%
2018 346.531.000.000 -1.98%
2019 305.820.000.000 -13.31%
2020 318.352.000.000 3.94%
2021 352.246.000.000 9.62%
2022 398.371.000.000 11.58%
2023 427.376.000.000 6.79%
2023 442.233.000.000 3.36%
2024 509.616.000.000 13.22%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Kyowa Kirin Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
1999 0
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 48.094.000.000 100%
2009 0 0%
2010 44.064.000.000 100%
2011 47.927.000.000 8.06%
2012 44.776.000.000 -7.04%
2013 43.633.000.000 -2.62%
2014 47.667.000.000 8.46%
2015 51.518.000.000 7.48%
2016 53.792.000.000 4.23%
2017 49.155.000.000 -9.43%
2018 48.591.000.000 -1.16%
2019 53.511.000.000 9.19%
2020 52.312.000.000 -2.29%
2021 57.679.000.000 9.3%
2022 62.896.000.000 8.29%
2023 70.080.000.000 10.25%
2023 72.106.000.000 2.81%
2024 103.716.000.000 30.48%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Kyowa Kirin Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
1999 105.216.000.000
2000 106.233.000.000 0.96%
2001 108.387.000.000 1.99%
2002 110.239.000.000 1.68%
2003 102.671.000.000 -7.37%
2004 98.606.000.000 -4.12%
2005 101.448.000.000 2.8%
2006 100.726.000.000 -0.72%
2007 105.528.000.000 4.55%
2008 1.718.000.000 -6042.49%
2009 0 0%
2010 0 0%
2011 132.000.000 100%
2012 145.000.000 8.97%
2013 205.000.000 29.27%
2014 169.000.000 -21.3%
2015 0 0%
2016 0 0%
2017 112.957.000.000 100%
2018 119.807.000.000 5.72%
2019 117.316.000.000 -2.12%
2020 126.610.000.000 7.34%
2021 145.608.000.000 13.05%
2022 166.185.000.000 12.38%
2023 147.536.000.000 -12.64%
2023 163.078.000.000 9.53%
2024 172.240.000.000 5.32%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Kyowa Kirin Co., Ltd. EBITDA
Year EBITDA Growth
1999 43.044.000.000
2000 50.371.000.000 14.55%
2001 52.952.000.000 4.87%
2002 33.544.000.000 -57.86%
2003 52.505.000.000 36.11%
2004 45.453.000.000 -15.51%
2005 37.096.000.000 -22.53%
2006 40.167.000.000 7.65%
2007 56.665.000.000 29.11%
2008 119.195.000.000 52.46%
2009 0 0%
2010 117.648.000.000 100%
2011 118.621.000.000 0.82%
2012 83.792.000.000 -41.57%
2013 83.927.000.000 0.16%
2014 67.856.000.000 -23.68%
2015 75.626.000.000 10.27%
2016 64.712.000.000 -16.87%
2017 78.812.000.000 17.89%
2018 97.253.000.000 18.96%
2019 64.601.000.000 -50.54%
2020 73.028.000.000 11.54%
2021 80.665.000.000 9.47%
2022 87.136.000.000 7.43%
2023 175.908.000.000 50.47%
2023 116.938.000.000 -50.43%
2024 123.996.000.000 5.69%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Kyowa Kirin Co., Ltd. Gross Profit
Year Gross Profit Growth
1999 126.872.000.000
2000 123.945.000.000 -2.36%
2001 128.744.000.000 3.73%
2002 126.328.000.000 -1.91%
2003 129.507.000.000 2.45%
2004 132.113.000.000 1.97%
2005 126.983.000.000 -4.04%
2006 131.425.000.000 3.38%
2007 144.918.000.000 9.31%
2008 200.297.000.000 27.65%
2009 0 0%
2010 190.979.000.000 100%
2011 197.555.000.000 3.33%
2012 210.691.000.000 6.23%
2013 212.761.000.000 0.97%
2014 205.904.000.000 -3.33%
2015 225.394.000.000 8.65%
2016 208.493.000.000 -8.11%
2017 224.321.000.000 7.06%
2018 227.189.000.000 1.26%
2019 226.200.000.000 -0.44%
2020 237.912.000.000 4.92%
2021 264.397.000.000 10.02%
2022 311.456.000.000 15.11%
2023 307.664.000.000 -1.23%
2023 320.621.000.000 4.04%
2024 362.116.000.000 11.46%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Kyowa Kirin Co., Ltd. Net Profit
Year Net Profit Growth
1999 11.274.000.000
2000 9.395.000.000 -20%
2001 5.535.000.000 -69.74%
2002 8.485.000.000 34.77%
2003 10.017.000.000 15.29%
2004 17.932.000.000 44.14%
2005 16.273.000.000 -10.19%
2006 12.694.000.000 -28.19%
2007 23.477.000.000 45.93%
2008 11.726.000.000 -100.21%
2009 0 0%
2010 22.197.000.000 100%
2011 25.608.000.000 13.32%
2012 24.199.000.000 -5.82%
2013 30.078.000.000 19.55%
2014 15.898.000.000 -89.19%
2015 29.774.000.000 46.6%
2016 18.669.000.000 -59.48%
2017 42.899.000.000 56.48%
2018 54.414.000.000 21.16%
2019 37.674.000.000 -44.43%
2020 47.027.000.000 19.89%
2021 52.347.000.000 10.16%
2022 53.573.000.000 2.29%
2023 127.632.000.000 58.03%
2023 81.188.000.000 -57.21%
2024 92.576.000.000 12.3%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Kyowa Kirin Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1999 26
2000 22 -23.81%
2001 13 -75%
2002 19 36.84%
2003 23 17.39%
2004 42 43.9%
2005 38 -7.89%
2006 31 -22.58%
2007 59 46.55%
2008 20 -190%
2009 0 0%
2010 39 100%
2011 45 15.56%
2012 44 -2.27%
2013 55 18.52%
2014 29 -86.21%
2015 54 46.3%
2016 56 1.82%
2017 78 29.49%
2018 101 22.77%
2019 70 -46.38%
2020 88 20.69%
2021 97 10.31%
2022 100 2.02%
2023 237 58.23%
2023 151 -56.95%
2024 174 13.22%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Kyowa Kirin Co., Ltd. Free Cashflow
Year Free Cashflow Growth
1999 10.236.000.000
2000 11.462.000.000 10.7%
2001 5.124.000.000 -123.69%
2002 5.410.000.000 5.29%
2003 25.062.000.000 78.41%
2004 22.839.000.000 -9.73%
2005 5.302.000.000 -330.76%
2006 10.341.000.000 48.73%
2007 16.312.000.000 36.6%
2008 22.839.000.000 28.58%
2010 28.717.000.000 20.47%
2011 23.145.000.000 -24.07%
2012 32.208.000.000 28.14%
2013 22.159.000.000 -45.35%
2014 -15.275.000.000 245.07%
2015 46.430.000.000 132.9%
2016 36.511.000.000 -27.17%
2017 42.569.000.000 14.23%
2018 36.039.000.000 -18.12%
2019 32.400.000.000 -11.23%
2020 4.274.000.000 -658.07%
2021 66.780.000.000 93.6%
2022 20.006.000.000 -233.8%
2023 82.699.000.000 75.81%
2023 17.319.000.000 -377.5%
2024 1.219.000.000 -1320.75%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Kyowa Kirin Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
1999 32.737.000.000
2000 28.789.000.000 -13.71%
2001 16.955.000.000 -69.8%
2002 18.193.000.000 6.8%
2003 34.264.000.000 46.9%
2004 30.104.000.000 -13.82%
2005 14.303.000.000 -110.47%
2006 23.381.000.000 38.83%
2007 30.714.000.000 23.88%
2008 41.069.000.000 25.21%
2010 64.189.000.000 36.02%
2011 40.634.000.000 -57.97%
2012 59.134.000.000 31.28%
2013 56.884.000.000 -3.96%
2014 19.377.000.000 -193.56%
2015 66.526.000.000 70.87%
2016 65.752.000.000 -1.18%
2017 64.903.000.000 -1.31%
2018 56.181.000.000 -15.52%
2019 53.657.000.000 -4.7%
2020 39.501.000.000 -35.84%
2021 86.546.000.000 54.36%
2022 48.672.000.000 -77.81%
2023 115.551.000.000 57.88%
2023 23.944.000.000 -382.59%
2024 27.646.000.000 13.39%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Kyowa Kirin Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
1999 22.501.000.000
2000 17.327.000.000 -29.86%
2001 11.831.000.000 -46.45%
2002 12.783.000.000 7.45%
2003 9.202.000.000 -38.92%
2004 7.265.000.000 -26.66%
2005 9.001.000.000 19.29%
2006 13.040.000.000 30.97%
2007 14.402.000.000 9.46%
2008 18.230.000.000 21%
2010 35.472.000.000 48.61%
2011 17.489.000.000 -102.82%
2012 26.926.000.000 35.05%
2013 34.725.000.000 22.46%
2014 34.652.000.000 -0.21%
2015 20.096.000.000 -72.43%
2016 29.241.000.000 31.27%
2017 22.334.000.000 -30.93%
2018 20.142.000.000 -10.88%
2019 21.257.000.000 5.25%
2020 35.227.000.000 39.66%
2021 19.766.000.000 -78.22%
2022 28.666.000.000 31.05%
2023 32.852.000.000 12.74%
2023 6.625.000.000 -395.88%
2024 26.427.000.000 74.93%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Kyowa Kirin Co., Ltd. Equity
Year Equity Growth
1999 199.041.000.000
2000 197.059.000.000 -1.01%
2001 213.098.000.000 7.53%
2002 220.498.000.000 3.36%
2003 226.430.000.000 2.62%
2004 236.899.000.000 4.42%
2005 257.491.000.000 8%
2006 244.082.000.000 -5.49%
2007 256.758.000.000 4.94%
2008 543.070.000.000 52.72%
2009 540.343.000.000 -0.5%
2010 544.992.000.000 0.85%
2011 540.023.000.000 -0.92%
2012 555.897.000.000 2.86%
2013 595.413.000.000 6.64%
2014 605.367.000.000 1.64%
2015 614.856.000.000 1.54%
2016 600.744.000.000 -2.35%
2017 616.028.000.000 2.48%
2018 649.621.000.000 5.17%
2019 678.250.000.000 4.22%
2020 698.396.000.000 2.88%
2021 737.162.000.000 5.26%
2022 762.826.000.000 3.36%
2023 836.418.000.000 8.8%
2023 812.143.000.000 -2.99%
2024 862.688.000.000 5.86%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Kyowa Kirin Co., Ltd. Assets
Year Assets Growth
1999 433.958.000.000
2000 431.411.000.000 -0.59%
2001 430.113.000.000 -0.3%
2002 368.772.000.000 -16.63%
2003 361.096.000.000 -2.13%
2004 374.493.000.000 3.58%
2005 384.381.000.000 2.57%
2006 378.871.000.000 -1.45%
2007 394.081.000.000 3.86%
2008 699.041.000.000 43.63%
2009 695.268.000.000 -0.54%
2010 695.862.000.000 0.09%
2011 658.873.000.000 -5.61%
2012 679.341.000.000 3.01%
2013 719.255.000.000 5.55%
2014 719.134.000.000 -0.02%
2015 720.762.000.000 0.23%
2016 697.166.000.000 -3.38%
2017 708.295.000.000 1.57%
2018 741.982.000.000 4.54%
2019 784.453.000.000 5.41%
2020 801.290.000.000 2.1%
2021 921.872.000.000 13.08%
2022 939.881.000.000 1.92%
2023 1.025.942.000.000 8.39%
2023 1.004.051.000.000 -2.18%
2024 1.070.009.000.000 6.16%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Kyowa Kirin Co., Ltd. Liabilities
Year Liabilities Growth
1999 234.917.000.000
2000 234.352.000.000 -0.24%
2001 217.015.000.000 -7.99%
2002 148.274.000.000 -46.36%
2003 134.666.000.000 -10.11%
2004 137.594.000.000 2.13%
2005 126.890.000.000 -8.44%
2006 134.789.000.000 5.86%
2007 137.323.000.000 1.85%
2008 155.971.000.000 11.96%
2009 154.925.000.000 -0.68%
2010 150.870.000.000 -2.69%
2011 118.850.000.000 -26.94%
2012 123.444.000.000 3.72%
2013 123.842.000.000 0.32%
2014 113.767.000.000 -8.86%
2015 105.906.000.000 -7.42%
2016 96.422.000.000 -9.84%
2017 92.267.000.000 -4.5%
2018 92.361.000.000 0.1%
2019 106.203.000.000 13.03%
2020 102.894.000.000 -3.22%
2021 184.710.000.000 44.29%
2022 177.055.000.000 -4.32%
2023 189.523.000.000 6.58%
2023 191.908.000.000 1.24%
2024 207.322.000.000 7.43%

Kyowa Kirin Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
895.8
Net Income per Share
183.15
Price to Earning Ratio
14.36x
Price To Sales Ratio
2.92x
POCF Ratio
13.7
PFCF Ratio
27.78
Price to Book Ratio
1.62
EV to Sales
2.31
EV Over EBITDA
7.84
EV to Operating CashFlow
10.75
EV to FreeCashFlow
21.96
Earnings Yield
0.07
FreeCashFlow Yield
0.04
Market Cap
1.388,18 Bil.
Enterprise Value
1.097,35 Bil.
Graham Number
2586.54
Graham NetNet
449.16

Income Statement Metrics

Net Income per Share
183.15
Income Quality
0.98
ROE
0.12
Return On Assets
0.09
Return On Capital Employed
0.13
Net Income per EBT
0.84
EBT Per Ebit
0.99
Ebit per Revenue
0.25
Effective Tax Rate
0.18

Margins

Sales, General, & Administrative to Revenue
0.34
Research & Developement to Revenue
0.18
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.72
Operating Profit Margin
0.25
Pretax Profit Margin
0.24
Net Profit Margin
0.2

Dividends

Dividend Yield
0.02
Dividend Yield %
2.2
Payout Ratio
0.31
Dividend Per Share
58

Operating Metrics

Operating Cashflow per Share
192.07
Free CashFlow per Share
94.03
Capex to Operating CashFlow
0.51
Capex to Revenue
0.11
Capex to Depreciation
2.23
Return on Invested Capital
0.11
Return on Tangible Assets
0.13
Days Sales Outstanding
96.83
Days Payables Outstanding
316.38
Days of Inventory on Hand
213.33
Receivables Turnover
3.77
Payables Turnover
1.15
Inventory Turnover
1.71
Capex per Share
98.04

Balance Sheet

Cash per Share
588,29
Book Value per Share
1.623,52
Tangible Book Value per Share
1065.22
Shareholders Equity per Share
1623.52
Interest Debt per Share
1.99
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-2.08
Current Ratio
3.52
Tangible Asset Value
566,02 Bil.
Net Current Asset Value
336,10 Bil.
Invested Capital
789983000000
Working Capital
389,02 Bil.
Intangibles to Total Assets
0.28
Average Receivables
121,20 Bil.
Average Payables
116,40 Bil.
Average Inventory
76066500000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Kyowa Kirin Co., Ltd. Dividends
Year Dividends Growth
2000 6
2001 8 14.29%
2002 8 0%
2003 8 0%
2004 8 0%
2005 11 36.36%
2006 10 -10%
2007 10 0%
2008 15 33.33%
2009 25 40%
2010 20 -25%
2011 20 0%
2012 20 0%
2013 25 20%
2014 25 0%
2015 25 0%
2016 25 0%
2017 27 7.41%
2018 35 22.86%
2019 42 16.67%
2020 44 4.55%
2021 46 4.35%
2022 48 4.17%
2023 56 14.29%
2024 58 3.45%

Kyowa Kirin Co., Ltd. Profile

About Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd. manufactures and markets pharmaceuticals that focuses on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor. The company also develops G-LASTA/Peglasta/Neulasta for chemotherapy-induced febrile neutropenia; LEUNASE for acute lymphoblastic leukemia; LUMICEF, a biological treatment for moderate to severe plaque psoriasis; Moventig, a mu-opioid receptor antagonist for the treatment of opioid induced constipation; Nouriast/ Nourianz, an adenosine receptor antagonist for Parkinson's disease; and ORKEDIA, an oral calcimimetics agent. In addition, it offers PecFent, a nasally administrated spray; POTELIGEO, a humanized monoclonal antibody for CC chemokine receptor 4; REGPARA for the treatment of secondary hyperparathyroidism; Romiplate/Nplate, a genetically recombinant protein for platelet production of thrombopoietin receptors; and SANCUSO for the treatment of nausea and vomiting. Kyowa Kirin Co., Ltd. has an agreement with Amgen Inc. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis. The company was formerly known as Kyowa Hakko Kirin Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in June 2019. The company was incorporated in 1949 and is headquartered in Tokyo, Japan. Kyowa Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.

CEO
Mr. Masashi Miyamoto Ph.D.
Employee
5.974
Address
Otemachi Financial City Grand Cube
Tokyo, 100-0004

Kyowa Kirin Co., Ltd. Executives & BODs

Kyowa Kirin Co., Ltd. Executives & BODs
# Name Age
1 Shoko Itagaki
Executive Officer & Chief People Officer
70
2 Hiroki Nakamura
Global Corporate Communications Head
70
3 Mr. Masashi Miyamoto Ph.D.
President, Chief Executive Officer & Representative Director
70
4 Mr. Yutaka Osawa M.B.A.
CCO, Executive Vice President & Representative Director
70
5 Yasuo Fujii M.B.A.
Chief Strategy Officer, Vice President & Managing Executive Officer
70
6 Hiroshi Sonekawa
Managing Executive Officer, Vice President and Head of Sales & Marketing Division
70
7 Mr. Takeyoshi Yamashita Ph.D.
Chief Medical Officer, Senior Managing Executive Officer & Director
70
8 Jean-David Rafizadeh-Kabe J.D., M.D.
Head of Global Operational Transformation
70
9 Mr. Motohiko Kawaguchi
Chief Financial Officer & Managing Executive Officer
70
10 Kazuki Nemoto
Head of Global Legal
70

Kyowa Kirin Co., Ltd. Competitors